| Name | Safeway Pharmacy #1460 |
|---|---|
| Organization Name | Nai Saturn Eastern Llc |
| Location | 1781 Forest Dr, Annapolis, Maryland 21401 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (410) 626-2717 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Pervasis Therapeutics, Inc. today announced that it has reached an agreement with the U.S. Food and Drug Administration (FDA) on the design of a pivotal Phase 3 clinical trial for Vascugel®, an investigational new drug for the prevention of hemodialysis access graft failure.
Democratic leaders are plotting campaigns to rally support for the health law and improve Democratic chances in the November elections. The hope is that "new insurance restrictions due to go into effect Sept. 23 and an accompanying public relations push will help turn the tide and give Democrats campaign-ready ammunition six weeks ahead of the midterm elections."
Insights into how the body clock and time of day influence immune responses are revealed today in a study published in leading international journal Nature Communications.
Almost half of patients with advanced lung cancer receive more than the recommended number of radiation treatments to reduce their pain, according to a new study published in the Journal of the National Cancer Institute.
› Verified 6 days ago
| NPI Number | 1043821416 |
| Organization Name | NAI SATURN EASTERN LLC |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 1781 Forest Dr, Annapolis, MD 21401 |
| Phone Number | 410-626-2716 |
News Archive
Pervasis Therapeutics, Inc. today announced that it has reached an agreement with the U.S. Food and Drug Administration (FDA) on the design of a pivotal Phase 3 clinical trial for Vascugel®, an investigational new drug for the prevention of hemodialysis access graft failure.
Democratic leaders are plotting campaigns to rally support for the health law and improve Democratic chances in the November elections. The hope is that "new insurance restrictions due to go into effect Sept. 23 and an accompanying public relations push will help turn the tide and give Democrats campaign-ready ammunition six weeks ahead of the midterm elections."
Insights into how the body clock and time of day influence immune responses are revealed today in a study published in leading international journal Nature Communications.
Almost half of patients with advanced lung cancer receive more than the recommended number of radiation treatments to reduce their pain, according to a new study published in the Journal of the National Cancer Institute.
› Verified 6 days ago
| NPI Number | 1114963741 |
| Organization Name | NAI SATURN EASTERN LLC |
| Doing Business As | SAFEWAY PHARMACY #1460 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 1781 Forest Dr, Annapolis, MD 21401 |
| Phone Number | 410-626-2717 |
News Archive
Pervasis Therapeutics, Inc. today announced that it has reached an agreement with the U.S. Food and Drug Administration (FDA) on the design of a pivotal Phase 3 clinical trial for Vascugel®, an investigational new drug for the prevention of hemodialysis access graft failure.
Democratic leaders are plotting campaigns to rally support for the health law and improve Democratic chances in the November elections. The hope is that "new insurance restrictions due to go into effect Sept. 23 and an accompanying public relations push will help turn the tide and give Democrats campaign-ready ammunition six weeks ahead of the midterm elections."
Insights into how the body clock and time of day influence immune responses are revealed today in a study published in leading international journal Nature Communications.
Almost half of patients with advanced lung cancer receive more than the recommended number of radiation treatments to reduce their pain, according to a new study published in the Journal of the National Cancer Institute.
› Verified 6 days ago
News Archive
Pervasis Therapeutics, Inc. today announced that it has reached an agreement with the U.S. Food and Drug Administration (FDA) on the design of a pivotal Phase 3 clinical trial for Vascugel®, an investigational new drug for the prevention of hemodialysis access graft failure.
Democratic leaders are plotting campaigns to rally support for the health law and improve Democratic chances in the November elections. The hope is that "new insurance restrictions due to go into effect Sept. 23 and an accompanying public relations push will help turn the tide and give Democrats campaign-ready ammunition six weeks ahead of the midterm elections."
Insights into how the body clock and time of day influence immune responses are revealed today in a study published in leading international journal Nature Communications.
Almost half of patients with advanced lung cancer receive more than the recommended number of radiation treatments to reduce their pain, according to a new study published in the Journal of the National Cancer Institute.
› Verified 6 days ago
Care Plus Cvs/pharmacy #02549 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 2666 Riva Rd, Annapolis, Maryland 21401 Phone: (410) 573-1635 | |
Cvs Pharmacy #05926 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 123 Main St, Annapolis, Maryland 21401 Phone: (410) 295-3061 | |
Cvs Pharmacy # 02775 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 2601 Riva Road, Annapolis, Maryland 21401 Phone: (410) 571-2090 | |
Cvs Pharmacy # 02779 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 503 South Cherry Grove Avenue, Annapolis, Maryland 21401 Phone: (443) 482-3981 | |
Cvs Pharmacy #04225 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 975 Bay Ridge Rd, Annapolis, Maryland 21403 Phone: (410) 268-7688 |